Access cutting-edge esophageal cancer treatment through this clinical trial at a research site in Commack. Study-provided care at no cost to qualified participants.
Access esophageal cancer specialists in Commack at no cost
This study follows strict safety protocols and ethical guidelines
All study-related esophageal cancer treatment provided free
The purpose of this study to find out whether adding trastuzumab and pembrolizumab to standard chemotherapy is an effective treatment for resectable HER2+ esophagogastric cancer.
Sponsor: Memorial Sloan Kettering Cancer Center
Check if you qualify for this esophageal cancer clinical trial in Commack, NY
If you're searching for esophageal cancer treatment options in Commack, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Commack research site is actively enrolling participants for this clinical trial. You'll receive care from experienced esophageal cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.